Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Fareva To Buy Pfizer Consumer Goods Plant

by Rick Mullin
September 5, 2011 | A version of this story appeared in Volume 89, Issue 36

Fareva, a contract manufacturer with headquarters in Luxembourg, has agreed to acquire Pfizer’s consumer products facility near Richmond, Va., for an undisclosed sum. Fareva plans to invest $42 million to expand the plant. The companies have also signed an agreement under which Fareva will continue to make consumer products for Pfizer. The 500 Pfizer employees at the plant will transfer to Fareva, and 90 positions will be added. “We have been looking for the right opportunity to expand our manufacturing footprint into North America,” says Fareva CEO Bernard Fraisse.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.